BioInformant

Your Global Leader in Stem Cell Market Research

  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • News
    • Interviews
  • Advertise
  • Shop
  • Company
    • Story
    • Testimonials
    • Submit PR
    • Job Posts
    • Privacy Policy
    • Guarantee
    • Contact
Home » News

Adaptimmune Receives RMAT Designation for ADP-A2M4 for Synovial Sarcoma

December 5, 2019 By Cade Hildreth (CEO) Leave a Comment

Adaptimmune RMAT

On December 3, 2019, Adaptimmune Therapeutics (Nasdaq:ADAP) announced it has been granted an Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. FDA for ADP-A2M4 in the treatment of Synovial Sarcoma. Previously, the FDA had awarded an Orphan Drug Designation (ODD) to ADP-A2M4 for the treatment of soft tissue sarcomas.

This RMAT designation represents the 38th publicly announced RMAT within the United States. [Read more…]

5 / 5 ( 1 vote )

Filed Under: News Tagged With: RMAT

What is an RMAT and Who Has One? | List of 38 RMAT Designations

December 4, 2019 By Cade Hildreth (CEO) 4 Comments

Advanced Therapy | What is a RMAT Designation (and Who Has One)?

As of today, the list of publicly announced RMAT’s has risen to 38. However, the U.S. FDA states it has received 115 total requests for RMAT designations and granted 44.

This means that slightly over one-third of RMAT applications get approved.

Adaptimmune Therapeutics T-cell therapy ADP-A2M4 for the treatment of Synovial Sarcoma was the most recent addition on December 3, 2019.

[Read more…]

4.9 / 5 ( 73 votes )

Filed Under: Cell Therapy, News Tagged With: RMAT

KATAOKA Introduces CPD-017 Cell Processor for High-Speed Biomanufacturing

November 26, 2019 By Cade Hildreth (CEO) Leave a Comment

Cell Processor CPD-017

Unwanted cell removal and cell sorting can be easily performed at high-speed.
 

TORRANCE, Calif. – Kataoka-SS America, a US subsidiary of Kataoka Corporation Kyoto Japan, has launched its sales of their Cell Processor CPD-017 to the U.S. market. Kataoka`s Cell Processor uses laser technology to scan, identify, and irradiate spontaneously differentiated cells without dissociation or applied stress to the cells.

With the CPD-017, the process time of purifying induced pluripotent stem cell (iPSC) is significantly reduced and the adherent cell colonies can maintain a stress-free healthy condition. [Read more…]

5 / 5 ( 7 votes )

Filed Under: News, Press Releases

CBR to Acquire Natera’s Evercord™ Cord Blood Business for an Undisclosed Sum

November 12, 2019 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Registry (CBR), a California Cryobank Life Sciences company, has announced it will acquire Natera’s Evercord™ cord blood business for an undisclosed sum. CBR is the largest newborn stem cell collection and storage company within the United States with more than 875,000 stem cell samples in storage. Natera is a publicly listed company (NASDAQ: NTRA) that specializes in genetic testing services. [Read more…]

5 / 5 ( 4 votes )

Filed Under: Cord Blood, News Tagged With: cord blood, Cord Blood Registry

Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineering

November 5, 2019 By Cade Hildreth (CEO)

National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board

REDWOOD CITY, Calif., Oct. 22, 2019 — Synthego, the leading genome engineering company, announced the launch of genome engineering for induced pluripotent stem (iPS) cells. The new offering expands Synthego’s automated cell editing to achieve unprecedented editing efficiency of iPS cells at an industrial scale. [Read more…]

5 / 5 ( 2 votes )

Filed Under: iPS Cells, News, Press Releases Tagged With: iPS cells

  • 1
  • 2
  • 3
  • …
  • 22
  • Next Page »

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Aspire

Marathon Products

Cellevate

Perinatal Stem cell Society

Menu
  • Blog
  • News
  • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • US Cord Blood and Cord Tissue Storage Rates Rates of U.S. Cord Blood and Cord Tissue Storage - Historical and Projected $197
  • Global Database of Stem Cell Therapy Companies - Featuring 100+ Companies $39
  • Defining the Future of the Stem Cell Industry: Interviews with Stem Cell Executives $197 $97

Featured Posts

Adaptimmune RMAT

Adaptimmune Receives RMAT Designation for ADP-A2M4 for Synovial Sarcoma

Feature | CAR-T Cell Therapy | What You Need To Know

What is CAR-T Cell Therapy? | CAR-T Definition

CAR T Cell Therapy

CAR-T Cell Therapy Attracts Vast Sums of Money

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Disclaimer

Copyright © 2019 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.